View in EDS

564P Investigating motor and bulbar severity in NT5c1A seropositive and seronegative IBM participants in the INSPIRE-IBM trial.

Saved in:
Bibliographic Details
Title: 564P Investigating motor and bulbar severity in NT5c1A seropositive and seronegative IBM participants in the INSPIRE-IBM trial.
Authors: Herrera, M.1 (AUTHOR), Wencel, M.1 (AUTHOR), Hernandez, I.1 (AUTHOR), Goyal, N.1 (AUTHOR), Dimachkie, M.2 (AUTHOR), Lloyd, T.3 (AUTHOR), Mohassel, P.3 (AUTHOR), Weihl, C.4 (AUTHOR), Freimer, M.5 (AUTHOR), Shaibani, A.6 (AUTHOR), Wicklund, M.7 (AUTHOR), Dixon, S.8 (AUTHOR), Chahin, N.9 (AUTHOR), Wang, L.10 (AUTHOR), Shieh, P.11 (AUTHOR), Amato, A.12 (AUTHOR), Quinn, C.13 (AUTHOR), Carbunar, O.14 (AUTHOR), Mozaffar, T.1 (AUTHOR)
Source: Neuromuscular Disorders. 2024 Supplement 1, Vol. 43, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09608966
DOI:10.1016/j.nmd.2024.07.164